| Ytd | 26.43% | |
| 1y | 9.48% |
| Open | 20.54 | Prev Close | 20.50 | Low | 20.30 | High | 20.57 | Mkt Cap | 14.41B |
| Vol | 10.23M | Avg Vol | 5.54M | EPS | 0.35 | P/E | 58.09 | Forward P/E | 145.14 |
| Beta | 0.99 | Short Ratio | 4.75 | Inst. Own | 97.73% | Dividend | 1.22 | Div Yield | 5.95 |
| Ex Div Date | 09-14 | Earning | 10-22 | 50-d Avg | 21.33 | 200-d Avg | 18.71 | 1yr Est | 23.00 |
NewEdge Advisors LLC boosted its stake in Healthpeak Properties, Inc. (NYSE: DOC) by 23.1% during th
Healthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro enviro
Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and l
Five S&P 500 stocks—VICI, PFE, VZ, T, F—offer 'safer' high yields, with free cash flow covering divi
Hsbc Holdings PLC decreased its holdings in Healthpeak Properties, Inc. (NYSE: DOC) by 12.8% in the
Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Healthpeak Properties, Inc. (NYSE: DOC) is a fully
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider eith
Adelante Capital Management LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE: DOC) in
Advisors Capital Management LLC raised its holdings in shares of Healthpeak Properties, Inc. (NYSE:
BlackRock Inc. trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE: DOC) by 3.3% during
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst r
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and ra
Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raise
Investors need to pay close attention to DOC stock based on the movements in the options market late
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform
Healthpeak Properties NYSE: DOC reported second-quarter adjusted funds from operations of $0.46 per
Healthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoi
On August 06, 2026, Healthpeak Properties Inc (DOC) shares fell 3.2% today, bringing the current pri
Cantor Fitzgerald analyst Richard Anderson maintains Healthpeak Properties (NYSE:DOC) with a Neut
Heathpeak tops Q2 FFO estimates as leasing gains and stronger senior housing results drive revenue g
Healthpeak Properties, Inc. (DOC) Q2 2026 Earnings Call Transcript
Healthpeak Properties remains in growth mode, supported by a well-covered 5.6% dividend yield and lo
First Trust Advisors LP grew its position in shares of Healthpeak Properties, Inc. (NYSE: DOC) by 11
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, beating the
Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.46 per share which beat the analy
Healthpeak Properties (NYSE:DOC) raises FY2026 FFO guidance from $1.71-$1.75 to $1.73-$1.77 vs $1.74
Healthpeak Properties, Inc. (NYSE:DOC) ("Healthpeak") and Brookfield Asset Management (NYSE:
Wells Fargo analyst John Kilichowski maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weig
Barclays analyst Richard Hightower initiates coverage on Healthpeak Properties (NYSE:DOC) with a
Mizuho analyst Vikram Malhotra maintains Healthpeak Properties (NYSE:DOC) with a Outperform and r
JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:DOC) with a Neutral and r
BMO Capital analyst Juan Sanabria maintains Healthpeak Properties (NYSE:DOC) with a Outperform an
Morgan Stanley analyst Richard Hill downgrades Healthpeak Properties (NYSE:DOC) from Overweight t
Wells Fargo analyst John Kilichowski maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weig
Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:DOC) with a Sector Perfo
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and ra
Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raise
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
High-dividend stocks are popular in uncertain markets. Benzinga has analyst ratings for many stocks,
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that